Literature DB >> 12827235

Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock.

Alexander Geppert1, Angela Steiner, Georg Delle-Karth, Gottfried Heinz, Kurt Huber.   

Abstract

OBJECTIVE: Patients in cardiogenic shock (CS) often present with signs of systemic inflammation that mimic infection, especially in the setting of multiple organ failure (MOF). To clarify the usefulness of procalcitonin (PCT) for diagnosing complicating sepsis in patients with CS, especially in the presence of MOF we compared PCT concentrations in patients with CS with and without MOF to those in patients with septic shock (SS). DESIGN AND
SETTING: Retrospective analysis in the cardiovascular ICU at a university hospital. PATIENTS: 40 patients with CS, 15 patients with SS, and 11 noncritically ill patients without infection. MEASUREMENTS AND
RESULTS: Infection was excluded by clinical and microbiological examination in all CS patients at the time of blood sampling. Nevertheless 35% exhibited CRP concentrations higher than 10 mg/dl and 25% PCT concentrations higher than 2 ng/ml. Median PCT concentrations were higher in CS patients than in controls but lower than in patients with SS. CS patients with MOF at the time of blood sampling exhibited higher PCT concentrations than patients without organ failure. In the pooled population of patients with CS and SS PCT had a higher area under the receiver operating characteristic curve (0.86 vs. 0.83) than CRP and a PCT concentration of 10 ng/ml or higher had greater specificity for sepsis than a PCT concentration of 2 ng/ml or higher but lower negative predictive value.
CONCLUSIONS: PCT concentrations above 2 ng/ml are frequently found in CS patients with MOF and do not necessarily indicate infection. PCT was slightly better than CRP for diagnosing sepsis in our study, but a PCT concentration of 10 ng/ml or higher seems to be more appropriate for diagnosing this complication in CS patients than 2 ng/ml.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827235     DOI: 10.1007/s00134-003-1827-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  21 in total

1.  Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation.

Authors:  S Hammer; F Meisner; P Dirschedl; G Höbel; P Fraunberger; B Meiser; B Reichardt; C Hammer
Journal:  Transpl Immunol       Date:  1998-12       Impact factor: 1.708

2.  Differentiated therapy with prostaglandin E1 (alprostadil) after orthotopic liver transplantation: the usefulness of procalcitonin (PCT) and hepatic artery resistive index (RI) for the evaluation of early graft function and clinical course.

Authors:  A Kornberg; T Grube; T Wagner; R Voigt; M Homman; U Schotte; K Schmidt; J Scheele
Journal:  Clin Chem Lab Med       Date:  2000-11       Impact factor: 3.694

3.  Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients.

Authors:  M Meisner; E Hüttemann; T Lohs; L Kasakov; K Reinhart
Journal:  Shock       Date:  2001-03       Impact factor: 3.454

4.  Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.

Authors:  B Müller; K L Becker; H Schächinger; P R Rickenbacher; P R Huber; W Zimmerli; R Ritz
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

5.  Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies.

Authors:  R Sabat; C Höflich; W D Döcke; M Oppert; F Kern; B Windrich; C Rosenberger; J Kaden; H D Volk; P Reinke
Journal:  Intensive Care Med       Date:  2001-06       Impact factor: 17.440

6.  Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients.

Authors:  A Aouifi; V Piriou; O Bastien; P Blanc; H Bouvier; R Evans; M Célard; F Vandenesch; R Rousson; J J Lehot
Journal:  Crit Care Med       Date:  2000-09       Impact factor: 7.598

7.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

8.  Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?

Authors:  Evangelos J Giamarellos-Bourboulis; Anna Mega; Paraskevi Grecka; Nektaria Scarpa; George Koratzanis; George Thomopoulos; Helen Giamarellou
Journal:  Intensive Care Med       Date:  2002-08-07       Impact factor: 17.440

9.  Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6.

Authors:  Alexander Geppert; Angela Steiner; Gerlinde Zorn; Georg Delle-Karth; Maria Koreny; Markus Haumer; Peter Siostrzonek; Kurt Huber; Gottfried Heinz
Journal:  Crit Care Med       Date:  2002-09       Impact factor: 7.598

10.  Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

View more
  17 in total

Review 1.  Procalcitonin in acute cardiac patients.

Authors:  Claudio Picariello; Chiara Lazzeri; Serafina Valente; Marco Chiostri; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2010-09-29       Impact factor: 3.397

Review 2.  The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers.

Authors:  Marin Nishimura; Alison Brann; Kay-Won Chang; Alan S Maisel
Journal:  Curr Heart Fail Rep       Date:  2018-08

3.  Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.

Authors:  Corsino Rey; Marta Los Arcos; Andrés Concha; Alberto Medina; Soledad Prieto; Pablo Martinez; Belen Prieto
Journal:  Intensive Care Med       Date:  2007-01-27       Impact factor: 17.440

4.  Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients.

Authors:  Nicolas Mongardon; Virginie Lemiale; Sébastien Perbet; Florence Dumas; Stéphane Legriel; Sylvie Guérin; Julien Charpentier; Jean-Daniel Chiche; Jean-Paul Mira; Alain Cariou
Journal:  Intensive Care Med       Date:  2009-10-21       Impact factor: 17.440

5.  Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention.

Authors:  Claudio Picariello; Chiara Lazzeri; Marco Chiostri; Gianfranco Gensini; Serafina Valente
Journal:  Intern Emerg Med       Date:  2009-07-08       Impact factor: 3.397

6.  Procalcitonin as an early diagnostic and monitoring tool in urosepsis following percutaneous nephrolithotomy.

Authors:  Ji Zheng; Qianwei Li; Weihua Fu; Jing Ren; Siji Song; Guoxian Deng; Jiwei Yao; Yongquan Wang; Weibing Li; Junan Yan
Journal:  Urolithiasis       Date:  2014-09-07       Impact factor: 3.436

7.  Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients.

Authors:  Michael Meisner; Heide Adina; Joachim Schmidt
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

8.  Kinetic of procalcitonin in patients with cardiogenic shock following acute myocardial infarction: preliminary data.

Authors:  C Picariello; C Lazzeri; M Chiostri; G F Gensini; S Valente
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2010

9.  Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction.

Authors:  René P Andrié; Ulrich M Becher; Ricarda Frommold; Vedat Tiyerili; Jan W Schrickel; Georg Nickenig; Jörg O Schwab
Journal:  Crit Care       Date:  2012-08-13       Impact factor: 9.097

Review 10.  Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit.

Authors:  John Alfred Carr
Journal:  J Intensive Care       Date:  2015-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.